New England Journal of Medicine· 2012Q1
Chromosomal Microarray versus Karyotyping for Prenatal Diagnosis
- 1,430citations
- Q1SCImago
- 2012year
Short summary
Chromosomal microarray analysis (CMA) identified clinically significant genetic information in 6.0% of prenatal samples with structural anomalies and 1.7% with advanced maternal age or positive screening, compared to karyotyping.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Pediatrics, Perinatology and Child Health
Pediatrics, Perinatology and Child HealthMedicine